Andy Fang (born 1992) is a Chinese-American billionaire and co-founder/CTO of DoorDash. He co-founded DoorDash in 2013 with Stanley Tang, Tony Xu, and Evan Moore. DoorDash's successful IPO in 2020 valued Fang's shares at $2.2 billion, making him a billionaire. Fang grew up in the San Francisco Bay Area and earned a computer science degree from Stanford University.
Presentation made at http://conferenciacrowdsourcing.com.br/ As melhores ideias, a inovação e a criatividade estão surgindo cada vez mais do lado de fora das empresas.
Trazê-las para o ambiente corporativo e transformar ideias em negócios, tem sido o maior desafio das empresas no mundo todo.
Durante a Conferência Crowdsourcing, Co-criação e Colaboração 2012, os principais especialistas no tema irão mostrar como
utilizar a produção coletiva e voluntária para criar melhores produtos e serviços.
Presentation made at http://conferenciacrowdsourcing.com.br/ As melhores ideias, a inovação e a criatividade estão surgindo cada vez mais do lado de fora das empresas.
Trazê-las para o ambiente corporativo e transformar ideias em negócios, tem sido o maior desafio das empresas no mundo todo.
Durante a Conferência Crowdsourcing, Co-criação e Colaboração 2012, os principais especialistas no tema irão mostrar como
utilizar a produção coletiva e voluntária para criar melhores produtos e serviços.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
1. Andy Fang
Born 1992 (age 29–30)
Nationality American
Alma mater Stanford University
Known for Co-founding
DoorDash
Andy Fang
Andy Fang (born 1992) is a Chinese-American billionaire tech
entrepreneur. He is best known as the co-founder and Chief
Technology Officer at DoorDash,[2][3] which he started along with
Stanley Tang, Tony Xu and Evan Moore in 2013.[4]
DoorDash had its IPO in December 2020,[5][6] making Fang's net
worth an estimated $2.2 billion as of December 2020.[7]
Fang grew up in the San Francisco Bay Area where he attended The Harker School, graduating in 2010.[8]
Fang has a bachelor's degree in Computer Science from Stanford University.[9]
1. "Forbes: Andy Fang" (https://www.forbes.com/profile/andy-fang/). Forbes. Retrieved
2021-01-23.
2. Levy, Steven (2015-11-09). "DoorDash Wants to Own the Last Mile" (https://www.wired.com/
2015/11/doordash-wants-to-own-the-last-mile/). Wired. Retrieved 2021-01-24.
3. "Goldhouse A100: Tony Xu, Andy Fang, Stanley Tang" (https://goldhouse.org/people/tony-xu
-andy-fang-stanley-tang/). Goldhouse. Retrieved 2021-01-24.
4. Manfredi, Lucas (2020-12-09). "DoorDash IPO turns CEO Tony Xu, co-founders Andy Fang,
Stanley Tang into billionaires" (https://www.foxbusiness.com/money/doordash-ipo-turns-ceo-
tony-xu-into-billionaire). FOXBusiness. Retrieved 2021-01-09.
5. Investor's Business Daily (2021-01-23). "Shares Of DoorDash IPO Jump By Double Digits
As Trading Begins" (https://www.investors.com/news/technology/doordash-ipo-initial-public-
offering-pricing-uber-dash/). Investor's Business Daily. Retrieved 2021-01-23.
6. Maloney, Tom (2020-12-09). "DoorDash Trio Worth Up to $2.8 Billion Each as IPO Soars" (ht
tps://www.bloomberg.com/news/articles/2020-12-09/doordash-ipo-delivers-billions-to-its-sta
nford-founders). Bloomberg. Retrieved 2021-01-23.
7. Sorvino, Chloe. "DoorDash IPO Delivers Three Billionaires As Wall Street Ignores A Menu
Of Losses" (https://www.forbes.com/sites/chloesorvino/2020/12/09/doordash-ipo-delivers-thr
ee-billionaires-as-wall-street-ignores-a-menu-of-losses/). Forbes. Retrieved 2021-01-23.
8. Bowes-Mokurl, Vikki (2018-12-20). "Dashing through life: DoorDash founder Andy Fang '10
– an alumni profile from Harker Magazine" (https://news.harker.org/dashing-through-life-door
dash-founder-andy-fang-10-an-alumni-profile-from-harker-magazine/). Harker Magazine.
Retrieved 2021-01-24.
9. "2015 30 Under 30: Consumer Technology" (https://www.forbes.com/pictures/54f4e6ffda47a
54de8244030/stanley-tang-22-andy-fang/?sh=33c324c9d334). Forbes. Retrieved
2021-01-22.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Andy_Fang&oldid=1051647772"
Personal life and education
References
2. This page was last edited on 24 October 2021, at 19:19 (UTC).
Text is available under the Creative Commons Attribution-ShareAlike License 3.0;
additional terms may apply. By
using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the
Wikimedia Foundation, Inc., a non-profit organization.